All Pharma articles – Page 20
-
-
SupplementsMedicine optimisation can cut the costs of long term conditions
The most effective use of medicines
-
LeaderHunt’s deal for doctors forces primary care to be top priority
GP plan cements Hunt’s plan for the NHS
-
HSJ KnowledgeMCP vanguard leaders: We will find the solutions
MCP vanguards report on their progress
-
NewsCall to extend hepatitis C drugs access after £190m funding boost
A charity has called for NHS England to allow all hepatitis C patients to access new treatments. It comes after the arm’s length body announced a much delayed commissioning policy for cirrhosis.
-
NewsExclusive: Efficiency rankings must not be 'crude weapon', Carter warns
Lord Carter has warned that the new metric he is developing to rate the productivity of every hospital in England must not be used as a ‘crude weapon’ in trust regulation.
-
SupplementsSupplement: 'The UK is out of sync' on bowel disease care
Improving care for IBD patients
-
-
CommentEnd Game: Lansley's parting policy potshots
He has no problem questioning the cancer drugs fund
-
NewsExclusive: HRA moves to stave off judicial review in clinical trial row
The Health Research Authority has moved to stave off a judicial review by a pharmaceutical company with links to the NHS in a dispute over transparency in clinical trials, HSJ has learned.
-
NewsExclusive: NHS England proposes new rare condition drug access rules
NHS England is set to publish new guidance, described by charities as ‘life saving’, on access to licensed drugs for patients with rare conditions and in ‘critical need’, HSJ has learned.
-
SupplementsRoundtable: Leading the way in developing new care models
The pros and cons of vanguard sites developing new care models
-
-
HSJ LocalOxford trust appoints new chief executive
WORKFORCE: Oxford University Hospitals Trust has appointed Dr Bruno Holthof as its chief executive.
-
HSJ LocalManchester commissioners to lobby over pharma deal money
FINANCE: Commissioners across Greater Manchester plan to lobby the government to ensure money given to the NHS by drug companies as part of a national pricing deal is available for use in the region.
-
NewsAstraZeneca president 'would not back pricing deal again'
The UK president of drug giant AstraZeneca has indicated she would not sign up to another deal similar to the current pharmaceutical pricing scheme unless the NHS makes a ‘substantial’ increase of drugs access.
-
NewsPolicy delays risk 'preventable deaths', doctors warn NHS England
Letter says rare conditions drug policy is a “matter of extreme urgency” Doctors warn patient access could be delayed until 2016-17 NHS England to set out timetable for new specialised commissioning process soon Twenty senior doctors and experts have written an open letter to the NHS England board ...
-
HSJ LocalPrivate ambulance provider investigated over security concerns
PERFORMANCE: A private ambulance provider used by an NHS trust in Kent is being investigated after an inspection found it was insecurely storing medicine at a hotel and employed staff who had not been security checked.
-
NewsMake drug shortages ‘never events’, say MPs
The next government has been urged to treat patient incidents caused by avoidable shortages in prescription medicines as ‘never events’ by a group of MPs.
-
NewsExclusive: NHS England labelled 'dysfunctional' over drug policy delay
NHS England has been accused of misleading government ministers and labelled a ‘dysfunctional organisation’ over delays in drawing up a prescribing policy for drugs to treat rare diseases.